SHP2 has been shown to regulate angiotensin-II-induced activation of JAK/STAT signaling in vascular smooth muscle cells4, mesangial cells23 and hepatocellular carcinoma cells24. This evidence concerns the gene AGT and hepatocellular carcinoma.